The Interleukin-2 Fusion Protein,$DAB_{389}$IL-2, Inhibits the Development of Infectious Virus in Human Immunodeficiency Virus Type 1: Infected Human Peripheral Blood Mononuclear Cells
$DAB_{389}$IL-2 is a genetically engineered fusion protein that reduces human immunodeficiency virus type 1 (HIV-1) replication in activated, interleukin (IL)-2 receptor (IL-2R)-expressing human peripheral blood mononuclear cells (PBMC). The level of infectious virus released by cultured PBMC after...
Gespeichert in:
Veröffentlicht in: | The Journal of infectious diseases 1997-04, Vol.175 (4), p.790-794 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!